Clinical Trials Browser

Interventional × Advanced Cancer × nabiximols × Clear all

NCT02432612 2016-03-02

A Study to Assess the Pharmacokinetic (PK) Properties of Sativex® in Patients With Advanced Cancer

Phase 1 Withdrawn

Advanced Cancer